(-0.20%) 5 057.00 points
(-0.05%) 37 974 points
(-0.47%) 17 489 points
(-1.04%) $81.08
(-2.81%) $1.935
(-0.22%) $2 297.90
(0.19%) $26.71
(-0.40%) $944.40
(0.12%) $0.938
(0.29%) $11.13
(0.12%) $0.801
(0.12%) $93.56
-0.99% ¥ 2 500.00
Live Chart Being Loaded With Signals
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies...
Stats | |
---|---|
Dagens volum | 81 900.00 |
Gjennomsnittsvolum | 61 533.00 |
Markedsverdi | 39.11B |
EPS | ¥0 ( 2024-04-12 ) |
Neste inntjeningsdato | ( ¥0 ) 2024-07-11 |
Last Dividend | ¥30.00 ( 2023-05-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 12.03 |
ATR14 | ¥1.285 (0.05%) |
Volum Korrelasjon
Daito Pharmaceutical Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Daito Pharmaceutical Korrelasjon - Valuta/Råvare
Daito Pharmaceutical Økonomi
Annual | 2022 |
Omsetning: | ¥45.10B |
Bruttogevinst: | ¥10.33B (22.91 %) |
EPS: | ¥227.64 |
FY | 2022 |
Omsetning: | ¥45.10B |
Bruttogevinst: | ¥10.33B (22.91 %) |
EPS: | ¥227.64 |
FY | 2022 |
Omsetning: | ¥43.46B |
Bruttogevinst: | ¥11.46B (26.36 %) |
EPS: | ¥335.41 |
FY | 2021 |
Omsetning: | ¥48.71B |
Bruttogevinst: | ¥10.79B (22.16 %) |
EPS: | ¥311.02 |
Financial Reports:
No articles found.
Daito Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥4.55 | 2010-05-27 |
Last Dividend | ¥30.00 | 2023-05-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 24 | -- |
Total Paid Out | ¥396.45 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.49 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.80 | |
Div. Directional Score | 7.50 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8358.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
7734.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6915.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
6277.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4992.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
4202.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3397.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
2487.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
9417.T | Ex Dividend Junior | 2024-06-27 | Annually | 0 | 0.00% | |
8079.T | Ex Dividend Knight | 2023-10-30 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0726 | 1.500 | 8.55 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0424 | 1.200 | 8.59 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0639 | 1.500 | -0.402 | -0.602 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.29 | 0.800 | 3.53 | 2.82 | [1 - 3] |
quickRatioTTM | 1.083 | 0.800 | 8.33 | 6.67 | [0.8 - 2.5] |
cashRatioTTM | 0.202 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0944 | -1.500 | 8.43 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 182.83 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.141 | -1.500 | 9.44 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.214 | 1.000 | 9.77 | 9.77 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0930 | 1.000 | -0.139 | -0.139 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.744 | 1.000 | 6.98 | 6.98 | [0.2 - 2] |
assetTurnoverTTM | 0.584 | 0.800 | 9.44 | 7.55 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 12.00 | 1.000 | 8.89 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0639 | 2.50 | -0.258 | -0.602 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.28 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.474 | 1.500 | -6.49 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.120 | 1.000 | 9.50 | 0 | [0.1 - 0.5] |
Total Score | 3.80 |
Daito Pharmaceutical
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.